Ceapro Inc V.CZO

Wellmune

[hoffbag]

Kerry is marketing YBG as Wellmune (maybe introduced in 2017?).  Offered in 60 countries.  Their talking point is immune boosting.  Also trying to differentiate in the market with process superiority (quality matters).

Gilles is a follower (and a ditherer).

Ceapro is a small company in a big company game.  They need to be faster and nimble, this is supposed to be an advantage of being small.  They will not succeed if they FOLLOW the market and because they are so SLOW they will die.  

Move faster please.  Sign deals and build plants.

[prophetoffacts]

This post has been removed in accordance with Community Policy

[prophetoffacts]

This post has been removed in accordance with Community Policy

[Ciao]

If I recall correctly, the plant in Germany is a given regardless of the results of the Y-BG study at McMaster as Y-BG as an immune booster was a market that Ceapro wanted to fulfill. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012169/ The market(s) for Y-BG that would be targeted depends on what results are obtained from McMaster. In addition the plant in Germany would be designed to produce

[prophetoffacts]

This post has been removed in accordance with Community Policy

[Ciao]

Wellmune's research studies and methodologies for data collection are heavily based on surveys. https://www.myhealth.be/wp-content/uploads/2018/12/Wellmune-Research-Summary-November-2018.pdf You can see why there is a need to have your health claims for a product backed up by true clinical research using the gold standard: double blind, placebo controlled study.

[prophetoffacts]

This post has been removed in accordance with Community Policy